Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis (Q38024326)

27 August 2017

0 references

Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis (English)

1 reference

polycystic ovary syndrome

27 August 2017

0 references

0 references

1 reference

1 reference

1 reference

S S Lim

1

1 reference

27 August 2017

M J Davies

series ordinal

2

1 reference

27 August 2017

R J Norman

series ordinal

3

1 reference

27 August 2017

L J Moran

series ordinal

4

1 reference

27 August 2017

4 July 2012

1 reference

Human Reproduction Update

27 August 2017

1 reference

27 August 2017

18

1 reference

27 August 2017

618-637

1 reference

27 August 2017

6

1 reference

Insulin-induced weight gain and cardiovascular events in patients with type 2 diabetes. A report from the DIGAMI 2 study

27 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The relationship between clinico-biochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Increased plasma thrombin-activatable fibrinolysis inhibitor levels in young obese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Hirsutism in Saudi females of reproductive age: a hospital-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Androgen excess in women: experience with over 1000 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Impact of body mass index on blood pressure levels in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The impact of obesity on hormonal parameters in hirsute and nonhirsute women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Polycystic ovary syndrome, body mass index and outcomes of assisted reproductive technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Correlates of increased lean muscle mass in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Menstrual dysfunction in rural young women and the presence of polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Body fat composition and distribution in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Endocrine effects of valproate in adolescent girls with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Metabolic syndrome in young women with the polycystic ovary syndrome: revisiting the threshold for an abnormally decreased high-density lipoprotein cholesterol serum level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Role of obesity and adiposity in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Screening women with polycystic ovary syndrome for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

A review of 1019 consecutive cases of polycystic ovary syndrome demonstrated by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Determinants of emotional distress in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The counterregulatory response to hypoglycaemia in women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: associations with recurrent pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughou

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The CC genotype of the GNAS T393C polymorphism is associated with obesity and insulin resistance in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Polycystic ovary syndrome and mental health: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Higher metabolic risk in Chinese women fulfilling the NIH diagnostic criteria for polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Hyperandrogenemia, psychological distress, and food cravings in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Metabolic syndrome in women with polycystic ovary syndrome: prevalence, characteristics and predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Tissue insulin sensitivity and body weight in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Predicting impaired glucose metabolism in women with polycystic ovary syndrome by decision tree modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Vascular function in the diagnostic categories of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Diabetes risk score in the diagnostic categories of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The impact of obesity on reproduction in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence and risk factors of overweight and obesity in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Arcsine test for publication bias in meta-analyses with binary outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Abnormal aminotransferase activity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Decreased adiponectin levels in polycystic ovary syndrome, independent of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Obesity, body composition and metabolic disturbances in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The global obesity pandemic: shaped by global drivers and local environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Serum leptin levels in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Adolescent BMI trajectory and risk of diabetes versus coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Body fat distribution modulates insulin sensitivity in post-menopausal overweight and obese women: a MONET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Effects of polycystic ovary syndrome on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Ethinylestradiol/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene and polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Impact of obesity on the risk for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS030

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMS030

1 reference

27 August 2017

1 reference